Antiretroviral Treatment Long-Term (ALT) Cohort: a prospective cohort of 10 years of ART-experienced patients in Uganda
dc.contributor.author | Castelnuovo, Barbara | |
dc.contributor.author | Mubiru, Frank | |
dc.contributor.author | Kiragga, Agnes N. | |
dc.contributor.author | Musomba, Rachel | |
dc.contributor.author | Mbabazi, Olive | |
dc.contributor.author | Gonza, Paul | |
dc.contributor.author | Kambugu, Andrew | |
dc.contributor.author | Ratanshi, Rosalind Parks | |
dc.date.accessioned | 2022-03-20T21:38:52Z | |
dc.date.available | 2022-03-20T21:38:52Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Castelnuovo, B., Mubiru, F., Kiragga, A. N., Musomba, R., Mbabazi, O., Gonza, P., ... & Ratanshi, R. P. (2018). Antiretroviral treatment Long-Term (ALT) cohort: a prospective cohort of 10 years of ART-experienced patients in Uganda. BMJ open, 8(2), e015490.http://dx.doi.org/10.1136/bmjopen-2016-015490 | en_US |
dc.identifier.uri | https://nru.uncst.go.ug/xmlui/handle/123456789/2841 | |
dc.description.abstract | Little information is available on patients on antiretroviral treatment (ART) after a long-term period from sub-Saharan Africa, with the longest follow-up and related outcomes being after 10 years on ART. At the Infectious Diseases Institute (IDI) (Kampala, Uganda), we set up a cohort of patients already on ART for 10 years at the time of enrolment, who will be followed up for additional 10 years. | en_US |
dc.language.iso | en | en_US |
dc.publisher | BMJ open | en_US |
dc.title | Antiretroviral Treatment Long-Term (ALT) Cohort: a prospective cohort of 10 years of ART-experienced patients in Uganda | en_US |
dc.type | Article | en_US |
Files in this item
This item appears in the following Collection(s)
-
Medical and Health Sciences [3718]